Lauren Molchan
Foot & Ankle Surgery · Denver, CONPI 1588160501
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (42.6%), other and education — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Convatec Inc. at 41.8% of the total. Reporting peaked in 2024 at $5,229 and has fallen 76.9% since, to $1,207 in 2025.
Across 86 payments — averaging $111.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Convatec Inc.$4K
- Smith+Nephew$2K
- Gemini Mountain Medical, LLC$1K
- Paragon 28, Inc.$698
- Treace Medical Concepts, Inc.$386
- Kerecis Limited$249
- plus $1K from 19 others
What the payments were for
- Travel & lodging$2963%
- Food & beverage$4,07243%
- Education$1,20013%
- Other$4,00042%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Convatec Inc. | 1 | $4,000 |
| Smith+Nephew | 27 | $1,903 |
| Gemini Mountain Medical, LLC | 2 | $1,230 |
| Paragon 28, Inc. | 9 | $698 |
| Treace Medical Concepts, Inc. | 5 | $386 |
| Kerecis Limited | 5 | $249 |
| Zimmer Biomet | 4 | $186 |
| Stryker | 8 | $173 |
| Bioventus LLC | 6 | $155 |
| Amgen | 1 | $118 |
| Novastep Inc. | 1 | $88 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $63 |
| Paratek Pharmaceuticals, Inc. | 3 | $60 |
| Nevro Corp. | 2 | $35 |
| Bristol Myers Squibb | 1 | $35 |
| Solventum Corporation | 1 | $26 |
| Integra Lifesciences Corporation | 1 | $23 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| Polynovo North America LLC | 1 | $21 |
| Siemens Medical Solutions USA, Inc. | 1 | $20 |
| Biotissue Holdings Inc. | 1 | $19 |
| Ossur Americas, Inc. | 1 | $15 |
| Vertex | 1 | $15 |
| Extremity Medical | 1 | $13 |
| Celularity Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$4,000
- Stravix$522
- STRAVIX PL$416
- APEX 3D$369
- GRAFIX PL$253
- Grafix$203
- Precision MIS Bunion$120
- Lapiplasty System$119
- KRYSTEXXA$118
- STRAVIX MESH$108
- TAPESTRY$103
How this compares
$9,568 in reported general payments places this provider in the 75th percentile of 181 foot & ankle surgery providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 38 | $792 |
| Methylprednisolone | 48 | $425 |
| Doxycycline Hyclate | 40 | $365 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 41 | $240 |
| Ondansetron Hcl | 29 | $132 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Denver
- Kevin NagamaniDenver$288K
- Keith JacobsonDenver$241K
- Stephen WallaceDenver$33K
- Marissa JamiesonDenver$30K
- Matthew GorskiDenver$14K
- Eric JaakolaDenver$14K
- Olivera JovicDenver$10K
- Emma KayalDenver$8K
- Michael HoughtonFort Collins$2M
- Joshua MetzlEnglewood$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.